Comparison of hypericum extract STW3 and sertraline in the treatment of mode-rate depression: A double-blind randomized 24-week-study;Hypericum-extrakt STW3 und sertralin zur behandlung der mittelschweren depression: Eine doppelblinde, randomisierte 24-Wochen-studie

Psychopharmakotherapie

Volumn 12, Issue 4, 2005, Pages 146-153

  Gastpar, Markus ^a,b   Zeller, Karin ^a,c  

^a Universität Duisburg Essen ^*

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Steigerwald Arzneimittelwerk GmbH   (Germany)

Author keywords

Clinical trial long term therapy; Depression; Selective serotonin reuptake inhibitor; St John's wort

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; HYPERICUM EXTRACT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HAMILTON SCALE; HERBAL MEDICINE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTICENTER STUDY; OUTPATIENT; PHASE 3 CLINICAL TRIAL; PSYCHOPHARMACOTHERAPY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 24744459663     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bracher A. Johanniskraut 1x täglich: Wirkung klinisch belegt/HYP611-Studie bestätigt Wirksamkeit. Verlagsbeilage Ärztliche Praxis 2001;5:1-4.
2. Brenner R, Azbel V. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomised pilot study. Clin Ther 2000;22:411-9.
3. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003;13:S69-S75.
4. Eisen SA, Miller DK, Woodward RS, Spitznagel E, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
5. van Gurp G, Meterissian GB, Haiek LN, McCusker J, et al. St. John's wart or sertraline? Randomized controlled trial in primary care. Can Fam Physician 2002;48:905-12.
6. Hübner WD, Arnoldt KH. Johanniskraut - Einjahresstudie. Z Phytother 2000;21:306-10.
7. Hypericum depression trial study group. Effect of hypericum perforatum (St. John's wart) in major depressive disorders - a randomized controlled trial. JAMA 2002;287:1807-14.
8. Kalb R, Trautmann-Sponsel RD, Kieser M. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 2001;34:96-103.
9. Kasper S. Hypericum perforatum - a review of clinical studies. Pharmacopsychiatry 2001;34(Suppl 1):51-5.
10. Kerb R, Brockmoller J, Staffeldt B, Ploch M, et al. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob Agents Chemother 1996;40:2087-93.
11. Kötter HU, Möller HJ, Hampel H. Sertralin: Ein moderner selektiver Serotonin-Wiederaufnahmehemmer in der antidepressiven Therapie. Arzneimitteltherapie 1999;17:395-401.
12. Laux G, Dietmaier O, König W. Pharmakopsychiatrie. München, Jena: Urban & Fischer Verlag, 2000.
13. Lemmer W, Von den Driesch V. Klieser E. Johanniskraut-Spezialextrakt WS 5572 bei leichter bis mittelschwerer Depression. Wirksamkeit und Verträglichkeit von Neuroplant 300 Filmtabletten. Fortschr Med Orig 1999;117:143-54.
14. Linde K, Ramirez G, Mulrow CD, Pauls A, et al. St. John's wart for depression (Cochrane Review). In: The Cochrane Library, Issue 3, 2003.
15. Oxford: update software - an overview and meta-analysis of randomised clinical trials. BMJ 1996;313:253-8.
16. Moscovitch A, Blashko CA, Eagles JM, Darcourt G, et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology 2003:[Epub ahead of print].
17. Philipp M, Kohen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicenter study of treatment for eight weeks. BMJ 1999;319:1534-9.
18. Rôder C, Schaefer M, Leucht S. Meta-Analyse zu Wirksamkeit und Verträglichkeit der Behandlung der leichten und mittelschweren Depression mit Johanniskraut. Fortschr Neurol Psychiatr 2004;72:330-43.
19. Rychlik R, Siedentop H, von den Driesch V, Kasper S. St. John's wart extract WS 5572 in minor to moderately severe depression. Effectiveness and tolerance of 600 and 1 200 mg active ingredient daily. Fortschr Med Orig 2001;119:119-28.
20. Schrader E. Equivalence of St. John's wart extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 2000;15:61-8.
21. Schulz V. The psychodynamic and pharmacodynamic effects of drugs: A differenciated evaluation of the efficacy of phytotherapy. Phytomed 2000;7:73-81.
22. Schulz V. Klinische Studien mit Hypericum-Extrakten bei Patienten mit Depressionen. Z Phytother 2002;23:11-5.
23. Schulz H-U, Schürer M, Bässler D, Weiser D. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Drug Res 2005;1:15-22.
24. Vorbach EU, Hübner WD, Arnoldt KH. Wirksamkeit und Verträglichkeit des Hypericum-Extraktes LI 160 im Vergleich mit Imipramin. Nervenheilkunde 1993;12:290-6.
25. Yyldyz A, Sachs GS. Administration of antidepressants. Single versus split dosing: a meta-analysis. J Affect Disord 2001;66:199-206.